000 01518 a2200337 4500
005 20250516095756.0
264 0 _c20130610
008 201306s 0 0 eng d
022 _a1433-2965
024 7 _a10.1007/s00198-012-2042-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSolomon, D H
245 0 0 _aDefining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges.
_h[electronic resource]
260 _bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_cJan 2013
300 _a237-44 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBisphosphonate-Associated Osteonecrosis of the Jaw
_xepidemiology
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aCohort Studies
650 0 4 _aDiphosphonates
_xadverse effects
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aOsteoporosis
_xdrug therapy
700 1 _aMercer, E
700 1 _aWoo, S B
700 1 _aAvorn, J
700 1 _aSchneeweiss, S
700 1 _aTreister, N
773 0 _tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
_gvol. 24
_gno. 1
_gp. 237-44
856 4 0 _uhttps://doi.org/10.1007/s00198-012-2042-6
_zAvailable from publisher's website
999 _c21872238
_d21872238